These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8473885)
1. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. Francis PT; Sims NR; Procter AW; Bowen DM J Neurochem; 1993 May; 60(5):1589-604. PubMed ID: 8473885 [No Abstract] [Full Text] [Related]
2. Neurotransmitters and second messengers in aging and Alzheimer's disease. Francis PT; Webster MT; Chessell IP; Holmes C; Stratmann GC; Procter AW; Cross AJ; Green AR; Bowen DM Ann N Y Acad Sci; 1993 Sep; 695():19-26. PubMed ID: 7902054 [TBL] [Abstract][Full Text] [Related]
3. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Simpkins JW; Singh M; Bishop J Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453 [No Abstract] [Full Text] [Related]
4. Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate. Deutsch SI; Morihisa JM Clin Neuropharmacol; 1988 Feb; 11(1):18-35. PubMed ID: 3280127 [No Abstract] [Full Text] [Related]
5. Alzheimer's disease in a patient with posterior cortical atrophy. Berthier ML; Leiguarda R; Starkstein SE; Sevlever G; Taratuto AL J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1110-1. PubMed ID: 1783928 [TBL] [Abstract][Full Text] [Related]
6. Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease. Chance SA; Clover L; Cousijn H; Currah L; Pettingill R; Esiri MM Cereb Cortex; 2011 Aug; 21(8):1870-8. PubMed ID: 21239393 [TBL] [Abstract][Full Text] [Related]
7. Life and death of neurons in the aging cerebral cortex. Morrison JH; Hof PR Int Rev Neurobiol; 2007; 81():41-57. PubMed ID: 17433917 [TBL] [Abstract][Full Text] [Related]
8. [Excitatory amino acids, the cerebral cortex and aging: a new perspective]. Mora F An R Acad Nac Med (Madr); 1991; 108(4):701-10. PubMed ID: 1688036 [No Abstract] [Full Text] [Related]
9. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia. Yew B; Nation DA; Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149 [TBL] [Abstract][Full Text] [Related]
10. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease. von Gunten A; Bouras C; Kövari E; Giannakopoulos P; Hof PR Brain Res Rev; 2006 Aug; 51(2):176-211. PubMed ID: 16413610 [TBL] [Abstract][Full Text] [Related]
11. Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Braak H; Braak E Prog Brain Res; 1986; 70():185-212. PubMed ID: 3575748 [No Abstract] [Full Text] [Related]
12. Editorial (Thematic Issue: Endocrine Disorders and Cognitive Function in the Elderly). Pasqualetti G; Calsolaro V; Monzani F Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):2-3. PubMed ID: 27981913 [No Abstract] [Full Text] [Related]
13. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. Hof PR; Cox K; Morrison JH J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598 [TBL] [Abstract][Full Text] [Related]
14. What are we seeing? Is posterior cortical atrophy just Alzheimer disease? Tang-Wai D; Mapstone M Neurology; 2006 Feb; 66(3):300-1. PubMed ID: 16476924 [No Abstract] [Full Text] [Related]